ArticleslgStudy

science

Sakigake (drug designation)

Sakigake (drug designation) is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Sakigake (drug designation) rather than just read about it. In short: Sakigake (さきがけ, lit. "pathfinder", "harbinger") is a drug designation by the Pharmaceuticals and Medical Devices Agency, the pharmaceuticals regulator of Japan. It was designed to provide easier access to novel advanced treatments.

Key takeaways

  • Sakigake (drug designation) belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Sakigake (drug designation) to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Sakigake (drug designation) from memory before moving on to harder problems.

Reference excerpt

Sakigake (さきがけ, lit. "pathfinder", "harbinger") is a drug designation by the Pharmaceuticals and Medical Devices Agency, the pharmaceuticals regulator of Japan. It was designed to provide easier access to novel advanced treatments. It is analogous to the Regenerative Medicine Advanced Therapy designation in the United States and the Advanced Therapy Medicinal Product designation in the European Union.

History The Sakigake designation was first announced as a pilot by the Ministry of Health, Labour and Welfare on 17 June 2014. The designation system is part of a wider strategy, also named Sakigake, to promote R&D and improve access to new pharmaceuticals. The Pharmaceutical & Medical Device Act Amendments of 2019, which entered into force on 1 September 2020, made the Sakigake designation system a permanent fixture. While application for the Sakigake designation was only open for a short period every year, the permanent Sakigake regime is open year-round.

Effect The Sakigake designation opens up the possibility for sponsors to seek pre-application consultations, which provide clients with a fixed-price multi-track review of their application.

Statistics As of 31 December 2020, 24 drugs received Sakigake designation, but only 8 of these (33.33%) were approved.

References

Worked examples

Example 1 — a first encounter with Sakigake (drug designation)

Start with the simplest possible case. Write down what Sakigake (drug designation) claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Sakigake (drug designation) before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Sakigake (drug designation) ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Sakigake (drug designation)

In research
Sakigake (drug designation) appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Sakigake (drug designation) in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Sakigake (drug designation) is common in secondary-school and first-year university syllabi. It links to neighbouring topics Pharmaceuticals policy, Pharmacology stubs, Regulation, so understanding it makes those chapters shorter.
In everyday life
Look for Sakigake (drug designation) outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Sakigake (drug designation)” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Sakigake (drug designation) in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Sakigake (drug designation) means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Sakigake (drug designation) out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Sakigake (drug designation) in simple terms?

Sakigake (さきがけ, lit. "pathfinder", "harbinger") is a drug designation by the Pharmaceuticals and Medical Devices Agency, the pharmaceuticals regulator of Japan. It was designed to provide easier access to novel advanced treatments.

Why does Sakigake (drug designation) matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Sakigake (drug designation)?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Sakigake (drug designation).

Tags

  • Pharmaceuticals policy
  • Pharmacology stubs
  • Regulation

Keep exploring